Filing Details
- Accession Number:
- 0001127602-15-009871
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-04 10:38:26
- Reporting Period:
- 2015-03-02
- Filing Date:
- 2015-03-04
- Accepted Time:
- 2015-03-04 10:38:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1454748 | Jr. T. James Boyle | 531 South Spring Street Burlington NC 27215 | Evp, Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-03-02 | 1,130 | $123.36 | 24,691 | No | 4 | F | Direct | |
Common Stock | Disposition | 2015-03-03 | 37 | $123.61 | 24,654 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-03 | 200 | $123.67 | 24,454 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-03 | 500 | $123.68 | 23,954 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-03 | 100 | $123.69 | 23,854 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-03 | 200 | $123.71 | 23,654 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-03 | 100 | $123.78 | 23,554 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-03 | 100 | $123.79 | 23,454 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Stock withholding to satisfy tax withholding obligations.
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.